Abbott India Q2 net profit up 23 percent at Rs 75 cr
New Delhi : Pharma firm Abbott India reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.
The company had posted a net profit of Rs 61.16 crore in the year-ago period, Abbott India said in a BSE filing.
Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.
Abbott India offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.
Shares of Abbott India closed 4.88 per cent higher at Rs 4,925 apiece on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd